Editorial: Klebsiella pneumoniae: Antimicrobial resistance, virulence and therapeutic strategies

Ning Dong; Ruichao Li; Yichyi Lai

doi:10.3389/fcimb.2022.1108817

Editorial: Klebsiella pneumoniae: Antimicrobial resistance, virulence and therapeutic strategies

Front Cell Infect Microbiol. 2022 Dec 23:12:1108817. doi: 10.3389/fcimb.2022.1108817. eCollection 2022.

Authors

Ning Dong^{1

2}, Ruichao Li^{3

4}, Yichyi Lai^{5

6}

Affiliations

¹ Department of Medical Microbiology, School of Biology and Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou, China.
² Suzhou Key Laboratory of Pathogen Bioscience and Anti-infective Medicine, Soochow University, Suzhou, China.
³ Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
⁴ Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
⁵ Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan, China.
⁶ Department of Microbiology and Immunology, School of Medicine, Chung Shan Medical University, Taichung, Taiwan, China.

No abstract available

Keywords: antimicrobial resistance (AMR); genomic analysis; host-pathogen interaction; klebsiella pneumoniae; molecular epidemiology; pathogenesis; virulence factors.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Drug Resistance, Bacterial
Klebsiella pneumoniae*
Virulence
Virulence Factors

Substances

Anti-Bacterial Agents
Virulence Factors